|
Feb 27
|
Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts
|
|
Feb 27
|
Novo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results
|
|
Feb 27
|
Denmark, home to Ozempic-maker Novo Nordisk, is now Europe’s third-most prosperous economy
|
|
Feb 26
|
25 Countries with Highest Tax to GDP Ratio in the World
|
|
Feb 26
|
Should You Continue to Add Novo Nordisk A/S (NVO) to Your Portfolio?
|
|
Feb 24
|
1 Wall Street Analyst Thinks Novo Nordisk Stock Is Going to $140. Is It a Buy?
|
|
Feb 23
|
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
|
|
Feb 22
|
GRAPHIC-Drugs, fashion and chips - the STOXX 600's 'Magnificent 4'
|
|
Feb 22
|
Here's 1 Pharmaceutical Stock That Looks Unstoppable. Hint: It's Not Novo Nordisk.
|
|
Feb 22
|
India pharma companies develop versions of Wegovy to get in on weight-loss windfall
|
|
Jan 16
|
Novo Nordisk (NVO) Dips More Than Broader Market: What You Should Know
|
|
Jan 16
|
5 Questions About Capitalism and Crises
|
|
Jan 16
|
Adaptimmune (ADAP) Surges More Than 80% in a Month: Here's Why
|
|
Jan 16
|
Dow Jones Falls 250 Points As Goldman Sachs Rallies On Earnings; Apple Tumbles On iPhone Discounts
|
|
Jan 16
|
Best Growth Stocks to Buy for January 16th
|
|
Jan 16
|
Is it a Good Idea to Buy Fusion Pharmaceuticals (FUSN) Stock Now?
|
|
Jan 16
|
4 Pharma Stocks to Buy, According to an Analyst. Novo Nordisk Isn’t One.
|
|
Jan 15
|
Dow Jones Futures Fall Amid Stellar Market Rally; Microsoft Leads Stocks In Buy Zones
|
|
Jan 15
|
Here is Why Growth Investors Should Buy Novo Nordisk (NVO) Now
|
|
Jan 15
|
Iovance (IOVA) Surges More Than 150% in 3 Months: Here's Why
|